OrthoPediatrics Corp. (NASDAQ:KIDS) Insider Gregory A. Odle Sells 5,359 Shares

OrthoPediatrics Corp. (NASDAQ:KIDS) insider Gregory A. Odle sold 5,359 shares of the firm’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $133,224.74. Following the sale, the insider now directly owns 148,788 shares of the company’s stock, valued at approximately $3,698,869.68. This trade represents a 3.48 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

OrthoPediatrics Stock Up 1.8 %

KIDS stock opened at $25.42 on Wednesday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. OrthoPediatrics Corp. has a fifty-two week low of $21.02 and a fifty-two week high of $35.99. The firm has a market capitalization of $617.38 million, a price-to-earnings ratio of -20.67 and a beta of 1.22. The company’s 50 day moving average price is $24.79 and its 200 day moving average price is $25.53.

OrthoPediatrics (NASDAQ:KIDS) last issued its earnings results on Tuesday, March 4th. The company reported ($0.29) EPS for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.04. The firm had revenue of $52.67 million during the quarter, compared to the consensus estimate of $51.16 million. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. During the same quarter in the previous year, the firm posted ($0.23) earnings per share. On average, equities research analysts anticipate that OrthoPediatrics Corp. will post -0.93 EPS for the current fiscal year.

Hedge Funds Weigh In On OrthoPediatrics

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Quarry LP purchased a new position in shares of OrthoPediatrics in the 3rd quarter valued at $25,000. R Squared Ltd purchased a new stake in shares of OrthoPediatrics in the 4th quarter valued at about $48,000. KLP Kapitalforvaltning AS acquired a new stake in shares of OrthoPediatrics in the 4th quarter valued at about $79,000. BNP Paribas Financial Markets grew its stake in OrthoPediatrics by 125.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock worth $94,000 after buying an additional 1,929 shares during the last quarter. Finally, Quantbot Technologies LP increased its position in OrthoPediatrics by 42.2% during the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company’s stock worth $157,000 after buying an additional 1,712 shares during the period. 69.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have commented on KIDS shares. Needham & Company LLC reaffirmed a “buy” rating and issued a $42.00 target price on shares of OrthoPediatrics in a research report on Wednesday, March 5th. Stifel Nicolaus dropped their target price on OrthoPediatrics from $40.00 to $32.00 and set a “buy” rating for the company in a research report on Wednesday, March 5th. Finally, Truist Financial lowered their price objective on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.